Soldato D, Arecco L, Agostinetto E, Franzoi M A, Mariamidze E, Begijanashvili S, Brunetti N, Spinaci S, Solinas C, Vaz-Luis I, Di Meglio A, Lambertini M
Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132, Genoa, Italy.
Oncol Ther. 2023 Jun;11(2):199-229. doi: 10.1007/s40487-023-00225-8. Epub 2023 Apr 1.
Prevalence of survivors of breast cancer has been steadily increasing in the last 20 years. Currently, more than 90% of women diagnosed with early-stage breast cancer are expected to be alive at 5 years from diagnosis thanks to early detection and breakthrough innovations in multimodal treatment strategies. Alongside this advancement in clinical outcomes, survivors of breast cancer might experience several specific challenges and present with unique needs. Survivorship trajectories after diagnosis and treatment of breast cancer can be significantly impacted by long-lasting and severe treatment-related side effects, including physical problems, psychological distress, fertility issues in young women, and impaired social and work reintegration, which add up to patients' individual risk of cancer recurrence and second primary malignancies. Alongside cancer-specific sequelae, survivors still present with general health needs, including management of chronic preexisting or ensuing conditions. Survivorship care should implement high-quality, evidence-based strategies to promptly screen, identify, and address survivors' needs in a comprehensive way and minimize the impact of severe treatment sequelae, preexisting comorbidities, unhealthy lifestyles, and risk of recurrence on quality of life. This narrative review focuses on core areas of survivorship care and discuss the state of the art and future research perspectives in key domains including selected long-term side effects, surveillance for recurrences and second cancers, well-being promotion, and specific survivors' needs.
在过去20年中,乳腺癌幸存者的比例一直在稳步上升。目前,由于早期检测和多模式治疗策略的突破性创新,超过90%被诊断为早期乳腺癌的女性预计在确诊后5年时仍然存活。伴随着临床治疗效果的这一进展,乳腺癌幸存者可能会面临一些特定挑战并呈现出独特需求。乳腺癌诊断和治疗后的生存轨迹可能会受到长期且严重的治疗相关副作用的显著影响,这些副作用包括身体问题、心理困扰、年轻女性的生育问题以及社会和工作重新融入方面的障碍,所有这些都会增加患者癌症复发和患第二原发性恶性肿瘤的个体风险。除了癌症特异性后遗症外,幸存者仍然存在一般健康需求,包括对慢性既往存在或后续出现的病症的管理。生存护理应实施高质量、基于证据的策略,以全面、及时地筛查、识别并满足幸存者的需求,并将严重治疗后遗症、既往合并症、不健康生活方式以及复发风险对生活质量的影响降至最低。本叙述性综述聚焦于生存护理的核心领域,并讨论关键领域的现状和未来研究前景,这些领域包括选定的长期副作用、复发和第二癌症的监测、促进健康以及特定幸存者的需求。